Astrotech Corporation (DE) Common Stock vs. Bio-Rad Laboratories, Inc.Class A
ASTC
Astrotech Corporation (DE) Common Stock
$6.13 -0.97%
VS BIOBio-Rad Laboratories, Inc.Class A
$376.41 -1.57%
Bio-Rad Laboratories, Inc.Class A (BIO) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| ASTC | BIO | |
|---|---|---|
| Market Cap | $12.92 million | $10.06 billion |
| Revenue (TTM) | $958,000 | $2.59 billion |
| Net Income (TTM) | $-14,090,000 | $222.40 million |
BIO leads on 3 of 3 size & scale factors.
Valuation
| ASTC | BIO | |
|---|---|---|
| P/E Ratio | — | 45.85 |
| Price / Book | 1.06 | 1.40 |
| Price / Sales | 13.49 | 3.89 |
ASTC and BIO split the valuation factors evenly.
Profitability
| ASTC | BIO | |
|---|---|---|
| Net Margin | -1470.77% | 8.59% |
| Return on Equity | -115.92% | 3.10% |
BIO leads on 2 of 2 profitability factors.
Risk & Sentiment
| ASTC | BIO | |
|---|---|---|
| Short Interest | 1.46% | 2.44% |
ASTC leads on 1 of 1 risk & sentiment factors.
Dig deeper: ASTC overview, ASTC financials, BIO overview, BIO financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.